드럭인포(Druginfo)-약품정보검색 - Medicinal information search & identification

About 드럭인포 (Druginfo) - 약품정보검색：

드럭인포 (Druginfo) - 약품정보검색 is the official mobile drug-information app from 드럭인포 / DRUGINFO, operated by Bit Computer, and built as the phone version of Drug Info (druginfo.co.kr). The Druginfo app is not a symptom checker or diagnosis tool — it is a Korean medicine reference for identifying pills, checking ingredients, reading permit/approval data, and reviewing DUR (Drug Utilization Review) information.

Pharmacists, clinicians, and general users open the Druginfo app to search a medicine by name, component, insurance code, or manufacturer — or to identify an unknown pill by marking, shape, color, score line, and imprint.

Store-ready features:

Medicine search — product name, ingredient, insurance code, manufacturer/seller inside the Druginfo app

Pill identification — search by marking, formulation, shape, color, score line, and logo/imprint

Medicine detail view — drug info, approval/permit data, ingredient breakdown, examination guidelines

DUR information — interaction and prescribing-review references

Mobile extension of druginfo.co.kr, curated for fast professional and public lookup

No third-party data sharing declared on Google Play; no data collected per current Play listing

Korean-first medical reference, rated 3+, free to install

How to Use the Druginfo App：

The Druginfo app runs on a lookup loop: open → search medicine → read details → identify unknown pill → check DUR → verify with a professional.

Quick guide:

Install 드럭인포 (Druginfo) - 약품정보검색 from Google Play.

Open the Druginfo app and use the search bar for a product name or ingredient.

Narrow results by insurance code or manufacturer/seller if the name is common.

Tap a result to read drug info, permit/approval data, ingredients, and examination guidelines.

Open 식별검색 / identification search for a pill you cannot name.

Enter marking, shape, color, formulation, and score line — the Druginfo app returns candidate matches.

Check DUR information before asking a pharmacist about combinations or repeat prescriptions.

Use the detail view to confirm ingredient overlap between prescribed and OTC medicines.

Keep the app updated — the April 2024 build fixed background-crash and identification-scroll bugs.

Treat every result as reference data: confirm with a pharmacist or clinician before changing medication.

Tips:

Identification works best when you combine imprint + shape + color, not just one attribute.

Search by ingredient, not brand name, when checking duplicate medicines from different pharmacies.

The Druginfo app is for information, not self-prescribing.

Druginfo FAQ and Status：

Who develops the app?

드럭인포 (DRUGINFO), with the service operated by Bit Computer Co., Ltd. The Play listing names the developer entity as 드럭인포(DRUGINFO) and Bit Computer.

What can I search in the Druginfo app?

Product name, active ingredient, insurance code, manufacturer/seller, plus pill identification by marking, shape, color, formulation, and score line.

Does it show DUR information?

Yes. The Druginfo app lists DUR-related medicine information alongside drug details, approval data, and ingredient info.

Is this the same as Druginfo Plus?

No. Druginfo Plus is the in-hospital/medical-institution service linked to HIS/OCS/EMR. The consumer app 드럭인포 (Druginfo) - 약품정보검색 is the public mobile extension of druginfo.co.kr.

Is my data shared?

The current Play data-safety section states no data shared with third parties and no data collected.

Why Install 드럭인포：

Install the Druginfo app if you handle Korean medicines and want a verified, database-driven reference instead of guessing from a pill’s appearance.

Best-fit users:

Pharmacists and pharmacy staff checking ingredients or insurance codes

Clinicians and nurses needing quick DUR/approval references

Patients identifying a prescribed or found pill by shape and marking

Caregivers managing multiple medications at home

Korean-language users who already trust druginfo.co.kr

Anyone checking duplicate ingredients across brands

Users who want a no-third-party-data-sharing medicine lookup